L-Arginine 1000 mg - 120 Tablets


Fragment Library: Shared: Product Fragments
Amino Acid

PRODUCT #: 0035
UPC: 733739000354

  • Double Strength
  • Conditionally Essential Amino Acid
  • Premium Grade
  • A Dietary Supplement

This product conforms to Good Manufacturing Practices (GMP)

L-Arginine is a conditionally essential basic amino acid involved primarily in urea metabolism and excretion, as well as DNA synthesis.*

Suggested Usage

As a dietary supplement, take 1 tablet 1 to 3 times daily as needed. Take between meals or at bedtime with a carbohydrate drink to facilitate absorption.

Keep the bottle tightly closed at all times in between usage. Keep the freshness packet in bottle.

Supplement Facts

Serving Size 1 Tablet
Servings Per Container 120
  Amount Per Serving % Daily Value
L-Arginine (from L-Arginine HCl)   1 g (1,000 mg)   †  
* Percent Daily Values are based on 2,000 calorie diet.
† Daily Value not established.


Other Ingredients:

Cellulose, Stearic Acid (vegetable source), Croscarmellose Sodium, Silica and Vegetarian Coating.


Details


Not manufactured with wheat, gluten, soy, milk, egg, fish, shellfish or tree nut ingredients. Produced in a GMP facility that processes other ingredients containing these allergens.

This product has twice the L-Arginine (1,000 mg per tablet) as in our regular strength product (500 mg per capsule).

Caution: For adults only. Consult physician if pregnant/nursing, taking medication, or have a medical condition. This supplement should be avoided by persons with glaucoma or herpes simplex unless otherwise prescribed by a physician. Do not use if you have had a myocardial infarction or have established coronary artery disease. Keep out of reach of children.

Do Not Eat Freshness Packet. Keep in Bottle.

Store in a cool, dry place after opening. Please Recycle.

Made in the USA

*This statement has not been evaluated by the Food and Drug Administration.  This product is not intended to diagnose, treat, cure or prevent any disease.

This information current as of 7/9/14 4:50 PM.